Epidemiological profile of patients diagnosed with HIV treated at a specialized care center in Vitória - ES in the post HAART era.
DOI:
https://doi.org/10.47456/rbps.v24isupl_1.39710Keywords:
HIV, Acquired immunodeficiency syndrome, Health profile, EpidemiologyAbstract
Introduction: The human immunodeficiency virus (HIV) was responsible for about 650,000 deaths worldwide, representing a disease of global impact. Objective: To describe the epidemiological profile of HIV-infected patients in the post-HAART era followed up at a specialized center for the treatment of PLHIV (SAE-HUCAM). Methods: Cross-sectional, retrospective study, with analysis of medical records in the SAE-HUCAM, between January 2019 and September 2022. Results: Of the 171 patients, 126 were men and 45 women (ratio for sex of 2.8), with a mean of age for both, 43 years. Brown skin color, 8-12 years of schooling (45.6%), heterosexuals (35.7%) and residence in urban areas (49.1%) predominated in the population. About 43.3% had comorbidities, the most prevalent being cardiovascular (50%). 58.5% came from the infectology ward. Only 36.8% had dropped out of treatment. 77.8% discovered HIV after 2017. CD4 count was low both in newly diagnosed patients (mean 274 cells/mm3) and treatment dropout (mean 205 cells/mm3). CD4 at the end of the study, evidenced 45% of the patients with a value above 500 cells/mm3. 36.8% had opportunistic infections, especially Candida spp. (18.6%). Conclusion: It is evident that despite the wide and unrestricted offer of HAART therapy, our population has a different epidemiological profile from PLHIV currently in Brazil. HIV infection still presents late, with opportunistic infections, without distinction between sex, age group over 40 years, in heterosexuals living in urban areas.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
